232 related articles for article (PubMed ID: 34445444)
1. Novel therapies for pediatric acute lymphoblastic leukemia.
Graff Z; Burke MJ; Gossai N
Curr Opin Pediatr; 2024 Feb; 36(1):64-70. PubMed ID: 37991046
[TBL] [Abstract][Full Text] [Related]
2. New treatments and strategies in acute myeloid leukemia.
Ravandi F
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1(0 1):S60-4. PubMed ID: 22035750
[TBL] [Abstract][Full Text] [Related]
3. Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia.
Stuani L; Sabatier M; Sarry JE
BMC Biol; 2019 Jul; 17(1):57. PubMed ID: 31319822
[TBL] [Abstract][Full Text] [Related]
4. HLX in AML: novel prognostic and therapeutic target.
Pandolfi A; Steidl U
Oncotarget; 2012 Oct; 3(10):1059-60. PubMed ID: 23888188
[No Abstract] [Full Text] [Related]
5. Editorial: Microenvironment and therapy-resistance in leukemias.
Friedmann R; Kim YM; Konopleva M
Front Oncol; 2023; 13():1244642. PubMed ID: 37519784
[No Abstract] [Full Text] [Related]
6. Patterns of undertreatment among patients with acute myeloid leukemia (AML): considerations for patients eligible for non-intensive chemotherapy (NIC).
Hubscher E; Sikirica S; Bell T; Brown A; Welch V; Russell-Smith A; D'Amico P
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3359-3368. PubMed ID: 34462785
[TBL] [Abstract][Full Text] [Related]
7. Stem Cells in Myelodysplastic Syndromes and Acute Myeloid Leukemia: First Cousins or Unrelated Entities?
Joudinaud R; Boyer T
Front Oncol; 2021; 11():730899. PubMed ID: 34490124
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and therapeutic implications of measurable residual disease in acute myeloid leukemia.
Aitken MJL; Ravandi F; Patel KP; Short NJ
J Hematol Oncol; 2021 Sep; 14(1):137. PubMed ID: 34479626
[TBL] [Abstract][Full Text] [Related]
9. Plant-derived extracts and metabolic modulation in leukemia: a promising approach to overcome treatment resistance.
Arévalo CM; Cruz-Rodriguez N; Quijano S; Fiorentino S
Front Mol Biosci; 2023; 10():1229760. PubMed ID: 37520325
[TBL] [Abstract][Full Text] [Related]
10. The development and benefits of metformin in various diseases.
Dong Y; Qi Y; Jiang H; Mi T; Zhang Y; Peng C; Li W; Zhang Y; Zhou Y; Zang Y; Li J
Front Med; 2023 Jun; 17(3):388-431. PubMed ID: 37402952
[TBL] [Abstract][Full Text] [Related]
11. Prospective Identification of Prognostic Hot-Spot Mutant Gene Signatures for Leukemia: A Computational Study Based on Integrative Analysis of TCGA and cBioPortal Data.
Zhang M; Lang X; Chen X; Lv Y
Mol Biotechnol; 2023 Nov; 65(11):1898-1912. PubMed ID: 36879146
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy induces plasmatic antioxidant changes in pediatric patients with acute lymphoid leukemia B that correlate to disease prognosis.
Garbim MR; Broto GE; Trigo FC; Victorino VJ; Oliveira ST; Barbosa Sabatini D; Panis C
Curr Res Immunol; 2022; 3():228-233. PubMed ID: 36189176
[TBL] [Abstract][Full Text] [Related]
13. Abnormal GRHL2 Methylation Confers Malignant Progression to Acute Leukemia.
Hua J; Ma C; Wang CH; Wang Y; Feng S; Xiao T; Zhu C
Appl Bionics Biomech; 2022; 2022():9708829. PubMed ID: 35855840
[TBL] [Abstract][Full Text] [Related]
14. Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells.
Zhao H; Jiang Y; Lin F; Zhong M; Tan J; Zhou Y; Liu L; Li G; Deng M; Xu B
Exp Hematol Oncol; 2022 May; 11(1):29. PubMed ID: 35581670
[TBL] [Abstract][Full Text] [Related]
15. Identification of a Mitochondria-Related Gene Signature to Predict the Prognosis in AML.
Jiang N; Zhang X; Chen Q; Kantawong F; Wan S; Liu J; Li H; Zhou J; Lu B; Wu J
Front Oncol; 2022; 12():823831. PubMed ID: 35359394
[TBL] [Abstract][Full Text] [Related]
16. The Emerging Roles of LINC00665 in Human Cancers.
Zhu J; Zhang Y; Chen X; Bian Y; Li J; Wang K
Front Cell Dev Biol; 2022; 10():839177. PubMed ID: 35356290
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Reprogramming and Cell Adhesion in Acute Leukemia Adaptation to the CNS Niche.
Sharma ND; Keewan E; Matlawska-Wasowska K
Front Cell Dev Biol; 2021; 9():767510. PubMed ID: 34957100
[TBL] [Abstract][Full Text] [Related]
18. Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma.
Nakamura A; Suzuki S; Kanasugi J; Ejiri M; Hanamura I; Ueda R; Seto M; Takami A
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639102
[TBL] [Abstract][Full Text] [Related]
19. Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia.
Di Martino L; Tosello V; Peroni E; Piovan E
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445444
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
